In 2019, Boehringer Ingelheim partnered with GreaterGood.org to join the fight against rabies in Puerto Rico. Over the next three years, we will donate doses of our leading rabies vaccine brand, IMRAB®, and proof of vaccination seals to help prevent rabies in 60,000 dogs and cats.
The number of stray dogs and cats is at an all-time high in Puerto Rico following Hurricane Maria1
IMRAB is the trusted rabies prevention with over 35 years of proven safety2
Rabies in Puerto Rico
A large population of wild mongooses in Puerto Rico poses a rabies threat to animals and people there.3 A mongoose research conducted by USDA wildlife services in Puerto Rico has shown that up to 40% of mongooses tested positive for rabies-virus neutralizing antibodies (RVNA), demonstrating prior peripheral viral exposure as well as evidence of active rabies virus circulation among mongooses in Puerto Rico.3,4 The donation through Shots for Good will help protect pets and stray dogs on the island from rabies.
Partnering for the Greater Good
Boehringer Ingelheim will spread the donations out over the next three years to support the SpayathonSM for Puerto Rico, a coalition of about two dozen groups, including Greatergood.org, organized by the Humane Society of the United States. The groups have offered spay/neuter and vaccination services to thousands of animals during several Spayathon events. Boehringer Ingelheim will serve as the rabies vaccination partner for the Spayathon events and is also donating tens of thousands of dollars to provide rabies seals that are required to show proof of vaccination. Additional rabies vaccines will be donated to Veterinarians for Puerto Rico, a nonprofit organization that will administer the vaccines in rural areas of the island.
GreaterGood.org is a nonprofit organization that is devoted to improving the health and well-being of people, pets, and the planet. It often aids animals following natural disasters such as Hurricane Maria. Veterinarians for Puerto Rico was founded by a group of Puerto Rican veterinarians following Hurricane Maria. Its main purpose is to provide veterinary care to underserved communities on the island.
Boehringer Ingelheim partnered with the Global Alliance for Rabies Control (GARC) in 2018 to donate 75,000 doses of rabies vaccine to Madagascar, where an estimated 200 people die from rabies each year.5